Therapeutic: odronextamab for blood cancers
Sanofi and Regeneron restructures immuno-oncology collaboration
GlobalData publishes analysis of top 25 global pharma companies
GlobalData names top 25 global pharma companies by market cap
Sanofi and Regeneron receive CHMP positive opinion for Kevzara
Sanofi and Regeneron announce Marketing Authorisation Application for Dupixent (dupilumab) accepted for review by the EMA
Curable initiates the International PSC Genome project in partnership with the Mayo Clinic
Regeneron names 2016 winners of the Regeneron Prize for Creative Innovation
Atopic dermatitis – dupilumab
Regeneron and Intellia Therapeutics form pact to develop CRISPR/Cas therapeutics
Regeneron and Bayer join forces to develop new combination therapy for eye diseases
Regeneron to create 200 new jobs as it invests US$350m in Limerick, Ireland
Sanofi and Regeneron to develop new antibody cancer treatments
Pipeline advancements and asset acquisitions fuelled mid-cap biotech R&D spend in 2014
Regeneron Pharmaceuticals to expand HQ and labs
